Physician profile
Jeffrey R Desantis
NPI 1659371748
$8,676.79
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $220 · 2021: $1,701 · 2022: $545 · 2023: $1,759 · 2024: $4,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,240 · Travel and Lodging: $1,409 · Gift: $1,039 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $980 · Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,240.00 |
| Travel and Lodging | $1,409.10 |
| Gift | $1,039.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $980.00 |
| Food and Beverage | $380.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $4,434.28 | 2023-2024 | Qutenza |
| Heron Therapeutics, INC. | $1,535.16 | 2021 | |
| Iq Med LLC | $1,412.17 | 2022-2023 | |
| Treace Medical Concepts, INC. | $514.62 | 2023 | |
| Horizon Therapeutics Plc | $141.36 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $131.36 | 2019-2020 | |
| Stryker Corporation | $108.16 | 2020-2021 | |
| Novastep INC. | $78.94 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.22 | 2022 | |
| Smith+Nephew, INC. | $36.99 | 2020-2022 | |
| Kerecis Limited | $36.51 | 2021 | |
| Collaborative Care Diagnostics, LLC | $33.80 | 2024 | |
| Integra Lifesciences Corporation | $29.52 | 2020 | |
| Saxum Surgical, INC. | $27.16 | 2023 | |
| Bard Peripheral Vascular, INC. | $22.71 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $19.24 | 2020 | |
| Tactile Systems Technology INC | $16.19 | 2021 | |
| Acell, INC. | $15.10 | 2020 | |
| Amniox Medical, INC. | $13.28 | 2020 | |
| Grt US Holding, INC. | $5.02 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$591,520.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Desantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.